Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Kidney in early atherosclerosis.

Alejandro R Chade1, Amir Lerman, Lilach O Lerman

  • 1Division of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA.

Hypertension (Dallas, Tex. : 1979)
|May 18, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Renovascular disease induces functionally relevant, locus-specific alterations to DNA methylation and hydroxymethylation in swine scattered tubular-like cells.

American journal of physiology. Renal physiology·2026
Same author

Vascular transcriptional and metabolic changes precede progressive intrarenal microvascular rarefaction in autosomal dominant polycystic kidney disease.

American journal of physiology. Renal physiology·2026
Same author

When in doubt, pig it out: a versatile translational platform to study CKD, HFpEF, and CKM syndrome.

American journal of physiology. Heart and circulatory physiology·2025
Same author

Renal Single-Nuclear Transcriptomics Identifies Novel Therapeutic Targets in a Preclinical Model of CKD.

Kidney360·2025
Same author

Vascular transcriptional and metabolic changes precede progressive intra-renal microvascular rarefaction in autosomal dominant polycystic kidney disease.

bioRxiv : the preprint server for biology·2025
Same author

Renal ischemia alters the mRNA and miRNA profile of vasculature-related genes in scattered tubular-like cells from female pigs.

American journal of physiology. Renal physiology·2025

Atherosclerosis, a major cause of death, is worsened by chronic kidney disease (CKD). This review explores how factors causing atherosclerosis can also initiate early kidney injury.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Pathophysiology

Background:

  • Atherosclerosis is a leading cause of premature death, often linked with chronic kidney disease (CKD).
  • CKD exacerbates atherosclerosis through various humoral and tissue mechanisms.
  • Risk factors like hypertension and diabetes damage kidneys and promote intrarenal atherogenesis.

Purpose of the Study:

  • To provide new insights into the mechanisms linking atherogenic factors to early renal injury.
  • To elucidate the dual role of the kidney in atherogenesis—as both a victim and a contributor.
  • To understand how traditional and non-traditional risk factors impact renal health and vascular disease.

Main Methods:

  • Review of existing literature on atherosclerosis and CKD.

Related Experiment Videos

  • Analysis of the interplay between systemic risk factors and renal pathophysiology.
  • Examination of molecular mechanisms including oxidative stress and inflammation.

    • Main Results:

    • Oxidative stress and inflammation are key mediators of risk factor effects on the kidney.
    • CKD progression can lead to dyslipidemia and uremic toxins, promoting vascular injury.
    • Atherogenic factors can instigate early renal damage, even without obstructive renal artery lesions.

    Conclusions:

    • The kidney plays a complex role in the development of atherosclerosis.
    • Understanding the mechanisms of early renal injury is crucial for managing patients with CKD and atherosclerosis.
    • Targeting oxidative stress and inflammation may offer therapeutic strategies for both conditions.